ABBOTINDIA - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 4.2
Show all parameters (20 more)
🧾 Chart Verdict
Short-term entry zones would be between 27,050 ₹ (support level at the DMA 200) and 27,600 ₹ (resistance aligned with the high of the recent channel). An exit strategy could involve a stop-loss order just below the DMA 200 at 26,554 ₹. The stock appears to be trending upwards in the short term, driven by momentum, however the elevated P/E ratio warrants cautious monitoring, particularly if volume declines or resistance levels are tested repeatedly.
✅ Positive
The stock is trading within a well-defined channel, exhibiting strong momentum indicated by the RSI and MACD readings. Furthermore, the recent quarterly profit growth (17.1%) provides underlying support to the price action.
⚠️ Limitation
Despite the positive indicators, the high P/E ratio of 35.9 relative to the industry average of 34.8 suggests a premium valuation that could create short-term resistance at higher levels. Significant volume spikes are required to confidently break through any potential resistance zones.
🏭 Industry
The pharmaceutical sector in India is currently experiencing moderate growth, driven by increasing healthcare spending and a growing domestic market. While competition remains intense, key players like Abbott are benefiting from established brands and expanding distribution networks, as highlighted in recent news reports.